ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer
Titel:
ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer
Auteur:
Matulonis, Ursula A. Lee, Julie Lasonde, Brian Tew, William P. Yehwalashet, Afra Matei, Daniela Behbakht, Kian Grothusen, Jill Fleming, Gini Lee, Nita K. Arnott, Jamie Bray, Mark R. Fletcher, Graham Brokx, Richard D. Castonguay, Vincent Mackay, Helen Sidor, Carolyn F. Oza, Amit M.